Psoriatic Arthritis

Top Story

Secukinumab yielded improvements for PsA through 2 years

September 19, 2017

In patients with active psoriatic arthritis, secukinumab yielded continued improvements in signs, symptoms and multiple clinical domains through 2 years of therapy, according to data from the FUTURE 2 study.

Five important news items about psoriatic arthritis

September 18, 2017 Rheumatology features five news items about psoriatic arthritis. More coverage can be found by clicking here.
Study: Poor sleep quality is

Study: Poor sleep quality is a feature of psoriatic disease

September 13, 2017
Among patients with psoriatic disease, poor sleep quality was prevalent and associated with fatigue, anxiety and lower EuroQol-5D scores, according to…

Chronic inflammatory rheumatic disease common in monoarthritis

September 6, 2017
Among patients with recent-onset arthritis, roughly one-fourth develop chronic inflammatory rheumatic disease after 2 years, according to findings. In the study…
More Headlines »

The Role of the Inflammatory Cascade in the Pathogenesis and Treatment of Psoriatic Arthritis: New and Emerging Therapies

This activity is supported by educational grants from Celgene Corporation and Novartis Pharmaceuticals Corporation.

The workings of the inflammatory cascade are not fully defined, but recent findings have demonstrated roles for novel…
More »
Meeting News Coverage

VIDEO: Give patients permission to experience discomfort as part of a safe yoga practice

August 5, 2016
More »
Resource Centers
Rheumatology Nurses Society Annual Conference

Rheumatology Nurses Society Annual Conference


Ace the Case: A 29-year-old Woman with Psoriasis Vulgaris

There is no commercial support for this activity.

This “Ace the Case” study will discuss the assessment and treatment of a 29-year-old woman with Psoriasis Vulgaris…
More »